← Back to Search

Reducing Unnecessary Care for Traumatic Injury

N/A
Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18-month interval (6 to 24 months) after implementation
Awards & highlights

Study Summary

This trial will study how to reduce unnecessary tests & procedures in injury admissions, leading to improved healthcare efficiency, cost savings & reduced adverse events.

Who is the study for?
This trial is for adult trauma centers in Québec's Trauma Care Continuum, specifically levels I-III. It aims to improve care for patients hospitalized with injuries by reducing unnecessary medical procedures. Level IV centers are excluded due to low patient volumes.Check my eligibility
What is being tested?
The study tests two approaches to reduce low-value clinical practices: usual practice with simple audit & feedback versus enhanced audit & feedback combined with educational outreach and facilitation. The goal is to see which method better reduces unnecessary tests and treatments.See study design
What are the potential side effects?
Since this trial focuses on process improvement rather than direct patient interventions, it does not involve medications or treatments that would typically have side effects. However, changes in care processes could potentially impact patient experiences.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18-month interval (6 to 24 months) after implementation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18-month interval (6 to 24 months) after implementation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Low-value initial diagnostic imaging
Secondary outcome measures
Low-value specialist consultation
Pre-transfer imaging
Repeat post-transfer imaging
Other outcome measures
Complications
Hospital stay
Incremental Cost-Effectiveness Ratios
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Simple audit & feedbackExperimental Treatment1 Intervention
The control arm will receive the quality improvement intervention currently in place in the Québec Trauma Care Continuum (i.e. simple A&F report presenting their performance compared to peers on quality indicators measuring adherence to high-value care and risk-adjusted outcomes) with the addition of quality indicators on low-value care (already planned by provincial authorities for the 2023 evaluation cycle). Simple A&F was chosen for the control because it is standard practice in Québec and in most integrated trauma systems and the effectiveness of A&F for de-implementation has been documented.
Group II: Audit & feedback with educational outreach and facilitationExperimental Treatment1 Intervention
The intervention includes: 1) refinement with end users, 2) an A&F report sent to local governing authorities presenting for each practice: performance compared to peers (simple A&F), a summary message indicating if action is required and a list of potential actions, 3) educational materials (a clinical vignette; consequences of the practice; links to practice guidelines, clinical decision rules and shared decision-making tools; a case review tool), 4) virtual educational meetings with the local trauma Medical Director, trauma program manager and data analyst, and 5) two virtual facilitation visits 2 and 4 months after the transmission of the report to support committees in preparing their action plan.

Find a Location

Who is running the clinical trial?

Trauma Association of CanadaUNKNOWN
Health Standards OrganisationUNKNOWN
Audit & Feedback MetalabUNKNOWN

Media Library

Simple audit & feedback Clinical Trial Eligibility Overview. Trial Name: NCT05744154 — N/A
Traumatic Injury Research Study Groups: Simple audit & feedback, Audit & feedback with educational outreach and facilitation
Traumatic Injury Clinical Trial 2023: Simple audit & feedback Highlights & Side Effects. Trial Name: NCT05744154 — N/A
Simple audit & feedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT05744154 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study actively seeking participants?

"Clinicaltrials.gov evidence indicates that this trial, which was first published on June 1st 2023 and last updated February 15th 2023, is no longer recruiting participants. Despite this unfortunate reality, there are presently 750 other clinical trials actively seeking patients to take part in the study."

Answered by AI
~17 spots leftby Sep 2025